Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Patent
1996-10-17
1998-08-25
Feisee, Lisa
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
530350, 530413, 5303882, 5303888, 53038885, 435326, 435330, 435346, C07K 1400, C07K 100, C07K 1600, C12N 500
Patent
active
057984450
ABSTRACT:
Monoclonal antibodies to adenocarcinoma cells, and, in particular, breast carcinoma cells, are produced by a hybridoma formed by fusing mouse lymphocytes and mouse myeloma cells. The monoclonal antibodies are capable of shrinking solid tumors associated with human breast. The monoclonal antibodies identify an antigen associated with carcinomas of ductal lineage. The monoclonal antibodies, specifically, F36/22 monoclonal antibodies, can be used diagnostically and therapeutically.
REFERENCES:
patent: 4486530 (1984-12-01), David et al.
Abe et al., J. Immunology, 139:257-261, 1987.
Ceriani et al., Somatic Cell Genetics, 9:415-427 (1983).
Colcher et al., PNAS 78:3197-3203 (1981).
Croghan et al., Fed. Proc. 42(3) Abstract 1576.
Croghan, Dissertation Abstracts International 44(10) (1984).
Day, ISI Press, 124-127 (1983).
Johnson et al., Cancer Res. 46:850-857 (1986).
McGee et al., The Lancet, Jul. 3, 1982 pp. 7-10.
Penn State University 1992-94 Graduate Degree Programs Bulletin, pp. 52-57.
Sevier et al., Clin. Chem. 27:1797-1806 (1981).
Boon, Adv. Can Res, 58:177-210, 1992.
Ezzell, J. Nih Res, 1995, 7:46-49.
Spitler, Can Biotherapy, 1995, 10:1-3.
Papsidero et al., 1984, Cancer Research 44:4653-4657.
Papsidero et al., 1984, Molec. Immunol. 21:955-960.
Croghan et al., 1983, Cancer Research 43:4980-4988.
Croghan et al., 1984, Cancer Research 44:1954-1962.
Herlyn et al., 1980, Cancer Res. 40:717-721.
Masui et al., 1984, Cancer Res. 44:1002-1007.
Chu et al., 1973, J. Natl. Cancer Inst. 51:1119-1122.
Ceriani et al., 1977, Proc. Natl. Acad. Sci. USA 74 : 582-586.
Ceriani et al., 1982, Proc. Natl. Acad, Sci. USA 79 : 5420-54.
Bale et al., 1980, Cancer Research 40 : 2965-2972.
Gregoriadis, 1977, Nature 265 : 407-411.
Trouet et al., 1980 Recent Results Cancer Res. 75 : 229-235.
Gregoriadis, 1980, Pharmac. Ther. 10 : 103-118.
Raso et al., 1982, Cancer Research 42 : 457-464.
Krolick et al., 1982, Nature 295 : 604-605.
Krolick et al., 1980, Proc. Natl. Acad. Sci. USA 77 : 5419-542.
Ghose et al., 1978, J. Natl. Cancer Inst. 61 : 657-675.
Arnon et al., 1982, Immunological Rev. 62 : 5-27.
DeWeger et al., 1982, Immunological Rev., 62 : 29-45.
Seto et al., 1982, Cancer Research, 42:5209-5215.
Scholm et al., 1982, Hybridomas in Cancer Diagnosis and Treatment edited by M.S. Mitchell and H.F. Oettgen, Raven Press, New York.
Nuti et al., 1982, Int. J. Cancer 29 : 539-454.
Colcher et al., 1983, Cancer Research 43 : 736-742.
Kufe et al., 1983, Cancer Research 43 : 851-857.
Hand et al., 1983, Cancer Research 43 : 728-735.
Taylor-Papadimitriou et al., 1981, Int. J. Cancer 28 : 17-21.
Arklie et al., 1981, Int. J. Cancer 28 : 23-29.
Papsidero et al., 1982, Hybridoma 1 (3) : 275-282.
Ciocca et al., 1982, Cancer Research 42 : 4256-4258.
Oldham, 1983, J. Clin. Oncol. 1 : 582-590.
Greene et al., 1980, Proc. Natl., Acad. Sci. USA 77 : 5115-5119.
Beverly, 1982, Nature 297 : 358-359.
Miller et al., 1982, The New England Journal of Medicine 306 : 517-522.
Young et al., 1981, Science 211 : 487-489.
Kirch et al., 1981, The J. of Immunol. 127 : 805-810.
Ritz et al., 1982, Blood 59 : 1-11.
Sears et al., Apr. 3, 1982, The Lancet, 762-765.
Herlyn et al., 1982, Proc. Natl. Acad. Sci. USA 79 : 4761-4765.
Adams et al, 1984, Proc. Natl. Acad. Sci. USA 81 : 3506-3510.
Chu Tsann Ming
Papsidero Lawrence D.
Feisee Lisa
Health Research , Inc.
Ungar Susan
LandOfFree
Purified ductal carcinoma antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purified ductal carcinoma antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purified ductal carcinoma antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-37114